Susquehanna Portfolio Strategies »

Halozyme Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 191k 73.34
2025-06-30 $9.8M 188k 52.02